JPMORGAN CHASE & CO - 31 Mar 2025 SCHEDULE 13G Report for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: RNAC
Shares outstanding: 27,469,443 shares
Disclosed Ownership: 1,675,636 shares
Ownership: 6.1%
Form type: SCHEDULE 13G
Filing time: 25 Apr 2025, 14:57:46 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	6.1%	1,675,636	1,569,254	0	Rachel Tsvaygoft	Vice President